Structure-activity relationships in platelet-activating factor (PAF) .7. Tetrahydrofuran derivatives as dual PAF antagonists and acetylcholinesterase inhibitors. Synthesis and PAF-antagonistic activity

被引:0
|
作者
LeTexier, L
Favre, E
Redeuilh, C
Blavet, N
Bellahsene, T
Dive, G
Pirotzky, E
Godfroid, JJ
机构
[1] UNIV PARIS 07,UNITE RECH CHIM & PHARMACOL,LAB PHARMACOCHIM MOL,F-75251 PARIS,FRANCE
[2] INST HENRI BEAUFOUR,F-92350 LE PLESSIS ROBINS,FRANCE
[3] UNIV LIEGE,INGN PROT LAB,INST CHIM,LIEGE,BELGIUM
来源
关键词
tetrahydrofuran; PAF antagonist; structure-activity relationship;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
2,5-Disubstituted tetrahydrofuran derivatives present a dual activity: they are effective PAF antagonists and acetylcholinesterase inhibitors. In this paper their synthesis and in vitro PAF-antagonistic effect are described. Introduction in position 2 of a long aliphatic chain bearing a carbamate group and a pyridinium moiety appears to be required for potent platelet aggregation inhibition, Substitution in position 5, or cis-trans isomerism do not induce any increase in activity. No correlation can be established between global lipophilicity and the anti-aggregant activity. Structural requirements for a potent activity are discussed and are consistent with the hypothesis we have proposed for the PAF receptor considered as a multipolarized structure with alternants of electropositive, electronegative and hydrophobic areas.
引用
收藏
页码:189 / 205
页数:17
相关论文
共 50 条
  • [1] Structure-activity relationships in platelet-activating factor (PAF) .8. Tetrahydrofuran derivatives as dual PAF antagonists and acetylcholinesterase inhibitors: Anti-acetylcholinesterase activity and comparative SAR
    LeTexier, L
    Favre, E
    Ronzani, N
    Massicot, F
    Blavet, N
    Pirotzky, E
    Godfroid, JJ
    JOURNAL OF LIPID MEDIATORS AND CELL SIGNALLING, 1996, 13 (03): : 207 - 222
  • [2] STRUCTURE-ACTIVITY RELATIONSHIP OF PLATELET ACTIVATING FACTOR (PAF) ANTAGONISTS
    OKANO, K
    ASANO, O
    SHIMOMURA, N
    KAWAHARA, T
    ABE, S
    MIYAZAWA, S
    MIYAMOTO, M
    YOSHIMURA, H
    NAGAOKA, J
    HARADA, K
    KAWATA, T
    YOSHIMURA, T
    SUZUKI, H
    SODA, S
    MACHIDA, Y
    KATAYAMA, K
    YAMATSU, I
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1989, 198 : 55 - MEDI
  • [3] Structure-activity relationships in platelet-activating factor (PAF). 10. From PAF antagonism to inhibition of HIV-1 replication
    Serradji, N
    Bensaid, O
    Martin, M
    Kan, E
    Dereuddre-Bosquet, N
    Redeuilh, C
    Huet, J
    Heymans, F
    Lamouri, A
    Clayette, P
    Dong, CZ
    Dormont, D
    Godfroid, JJ
    JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (11) : 2149 - 2154
  • [4] TETRAHYDROFURAN DERIVATIVES AS PAF-ACETHER ANTAGONISTS - STRUCTURE-ACTIVITY RELATIONSHIP
    HEYMANS, F
    REDEUILH, C
    MASSICOT, F
    WICHROWSKI, B
    FAVRE, E
    SPINEWYN, B
    BLAVET, N
    BRAQUET, P
    GODFROID, JJ
    PROSTAGLANDINS, 1988, 35 (05): : 845 - 845
  • [5] Regulation of platelet-activating factor (PAF) activity in human diseases by phospholipase A2 inhibitors, PAF acetylhydrolases, PAF receptor antagonists and free radical scavengers
    Peplow, PV
    PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 1999, 61 (02): : 65 - 82
  • [6] Inverse agonist activity of platelet-activating factor (PAF) receptor antagonists.
    Dupre, DJ
    Le Gouill, C
    Parent, JL
    Rola-Pleszczynski, M
    Stankova, J
    FASEB JOURNAL, 1999, 13 (04): : A466 - A466
  • [7] Platelet-activating factor (PAF) antagonists in foods: A study of lipids with PAF or anti-PAF-like activity in cow's milk and yogurt
    Antonopoulou, S
    Semidalas, CE
    Koussissis, S
    Demopoulos, CA
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 1996, 44 (10) : 3047 - 3051
  • [8] Structure-activity relationships in platelet-activating factor (PAF).: 11-From PAF-antagonism to phospholipase A2 inhibition:: syntheses and structure-activity relationships in 1-arylsulfamido-2-alkylpiperazines
    Binisti, C
    Assogba, L
    Touboul, E
    Mounier, C
    Huet, J
    Ombetta, JE
    Dong, CZ
    Redeuilh, C
    Heymans, F
    Godfroid, JJ
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2001, 36 (10) : 809 - 828
  • [9] Conformational considerations in the design of dual antagonists of platelet-activating factor (PAF) and histamine
    Kaminski, JJ
    Carruthers, NI
    Wong, SC
    Chan, TM
    Billah, MM
    Tozzi, S
    McPhail, AT
    BIOORGANIC & MEDICINAL CHEMISTRY, 1999, 7 (07) : 1413 - 1423
  • [10] Structure-activity relationships in platelet-activating factor. Part 14: Synthesis and biological evaluation of piperazine derivatives with dual anti-PAF and anti-HIV-1 activity
    Sallem, Wafa
    Serradji, Nawal
    Dereuddre-Bosquet, Nathalie
    Dive, Georges
    Clayette, Pascal
    Heymans, Francoise
    BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (23) : 7999 - 8013